It is conceivable that some patients may have borderline slow gastric emptying and starting one of the GLP-1 agonists may precipitate a full-blown gastroparesis, Michael Camilleri, a Mayo gastroenterologist who has studied GLP-1 antagonists and gastric emptying, told CNN , noting elsewhere that Knight, Wright, and others might just be really unlucky. Per the report, the Federal Drug Administration (FDA) says its received reports of gastroparesis amongst users of GLP-1 drugs
As regards pancreatic enzymes, only pancreatic isoamylases increased slightly under oral semaglutide therapy, but this increase was not significant compared with T0 at any time ( Table 3 )
See how B12 may fit into your wellness routine today
Weve got this extraordinary era were in where GLP-1s have become a phenomenon that even the drugmakers could not have predicted they are unable to meet the demand, said Scott Brunner, chief executive of the Alliance for Pharmacy Compounding